Metabolic syndrome associated with haemodynamic, inflammatory and psychological risk factors in a large French population study

In a large French population study including 101697 men and women who had a health check-up between 1997 and 2002 as part of the SYMFONIE study, the prevalence of the metabolic syndrome as defined by ATP III criteria among subjects =40 years was 5.0% in men and 2.2% in women, rising to 14.1% and 12.0% in men and women >70 years of age. This prevalence was lower than in North American and northern European populations. Compared to patients with no metabolic syndrome, patients with metabolic syndrome presented age-adjusted higher pulse pressure, higher heart rate, lower vital respiratory capacity, lower physical activity, increased inflammatory status as assessed by leukocyte count and dental inflammation, increased hepatic abnormalities, and increased levels of stress and depression.

Abstract